Shenzhen Lifotronic Technology Co - Asset Resilience Ratio
Shenzhen Lifotronic Technology Co (688389) has an Asset Resilience Ratio of 2.53% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Shenzhen Lifotronic Technology Co for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2024)
This chart shows how Shenzhen Lifotronic Technology Co's Asset Resilience Ratio has changed over time. See net assets of Shenzhen Lifotronic Technology Co for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shenzhen Lifotronic Technology Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shenzhen Lifotronic Technology Co stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥73.25 Million | 2.53% |
| Total Liquid Assets | CN¥73.25 Million | 2.53% |
Asset Resilience Insights
- Limited Liquidity: Shenzhen Lifotronic Technology Co maintains only 2.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shenzhen Lifotronic Technology Co Industry Peers by Asset Resilience Ratio
Compare Shenzhen Lifotronic Technology Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 48.75% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Shenzhen Lifotronic Technology Co (2024–2024)
The table below shows the annual Asset Resilience Ratio data for Shenzhen Lifotronic Technology Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.53% | CN¥73.25 Million ≈ $10.72 Million |
CN¥2.89 Billion ≈ $423.56 Million |
-- |
About Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound ca… Read more